Baxter International | BAX - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Abbott USD 3.6B 330M 2026-06
AngioDynamics USD 36.57M 3.79M 2025-09
Artivion USD 55.75M 4.54M 2025-12
AtriCure USD 82.56M 1.99M 2026-06
Baxter International USD 735M 7M 2026-06
Becton, Dickinson and Co. USD 1.26B 48M 2026-06
Boston Scientific USD 1.8B 22M 2026-06
Cooper Companies USD 676.2M 303.1M 2026-03
Dexcom USD 358.7M 9M 2026-06
Edwards Lifesciences USD 561.2M 39M 2026-06
Fresenius EUR 760M 17M 2026-06
Globus Medical USD 286.82M 10.95M 2026-06
Halozyme Therapeutics USD 57M 10.71M 2026-06
ICU Medical USD 151.92M 2.64M 2026-06
Inogen USD 43.77M 510K 2024-06
Insulet USD 344.8M 27.6M 2026-06
Integra LifeSciences USD 166.22M 12.01M 2026-06
Intuitive Surgical USD 617.9M 4.6M 2026-06
J&J USD 6.42B 381M 2026-06
Laboratory Of America USD 577.2M 26.2M 2026-06
Medtronic 2.96B 9M 2025-12
Merit Medical Systems USD 129.23M 18.76M 2026-06
Quest Diagnostics USD 529M 25M 2026-06
Smith & Nephew USD 1.45B 29M 2026-06
Stryker USD 2.12B 32M 2026-06
Tandem Diabetes Care USD 111.64M 3.45M 2026-06
Teleflex USD 213.52M 12.5M 2026-06
Terumo JPY 109.7B 5.11B 2026-06
Zimmer Biomet Holdings USD 911.6M 61.7M 2026-06